Is the Federal Drug Utilization Review Requirement Just Red Tape or an Enlightened State of Flexibility?

被引：0

作者：

Kleinrock, Michael ^{[1
]}

机构：

[1] IQVIA Inst Human Data Sci, Cape Town, South Africa

来源：

AMERICAN HEALTH AND DRUG BENEFITS | 2017年 / 10卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：482 / 482

页数：1

共 8 条

[1] Utilization review for red cell transfusions - Are we just going through the motions?
Goodnough, LT
Audet, AM
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (09) : 802 - 803
[2] DRUG UTILIZATION REVIEW - STATE-OF-THE-ART FROM AN ACADEMIC PERSPECTIVE
LIPTON, HL
BIRD, JA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) : 616 - 619
[3] DRUG UTILIZATION REVIEW IN AMBULATORY SETTINGS - STATE OF THE SCIENCE AND DIRECTIONS FOR OUTCOMES RESEARCH
LIPTON, HL
BIRD, JA
MEDICAL CARE, 1993, 31 (12) : 1069 - 1082
[4] Impact of US federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review
Mishuk, Ahmed Ullah
Fasina, Ifedolapo
Qian, Jingjing
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (06): : 736 - 745
[5] Radioactive red tape: How politics and overlapping federal and state jurisdictions thwart sensible solutions to the growing problem of radioactive waste disposal.
Codevilla, DA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1030 - U1030
[6] Retrospective drug utilization review software systems: Perspectives of state Medicaid DUR directors
Armstrong, EP
Proteau, D
ANNALS OF PHARMACOTHERAPY, 1996, 30 (10) : 1088 - 1091
[7] Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies
Prada, Sergio I.
AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (09): : 477 - 482
[8] Comparing the Medicaid Prospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies in 2015 and 2016
Prada, Sergio, I
Loaiza, Johan S.
AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (01): : 7 - 12

← 1 →